Aclaris Therapeutics, Inc.

Malvern, Pennsylvania 19355

0 studies enrolling now · 3 studies all time

What they study most

Seborrheic Keratosis

Studies at this site

• An Open-Label Safety Study of A-101 Solution — Completed
• A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis. — Completed
• A Randomized, Double-Blind, Vehicle-Controlled Study in Subjects With Seborrheic Keratosis — Completed